Georgia’s medical cannabis program is expanding even as state regulators wait for input from the DEA. Here’s why it matters and what DMV readers should watch.

Treasury and the IRS say tax guidance tied to cannabis rescheduling is a top priority for 2026–2027, with big implications for Section 280E and mixed medical/adult-use operators.

A new proposal dubbed Senate Bill 1 would route hemp-derived cannabinoids through pharmacies only, reshaping access, retail, and compliance—especially for delivery.

A plain‑English playbook for understanding marijuana delivery regulations, courier licensing and transport compliance—built for DC, Maryland and Virginia readers.

Weedmaps News flagged new coverage, but details are scarce. Here’s a DMV-first explainer to navigate cannabis delivery laws, licensing, and transport compliance without guessing.

State Democrats say adult-use marijuana in Pennsylvania won’t move without control of both legislative chambers. Here’s what’s known, what isn’t, and why DMV readers should care.

Curaleaf launched a hostile takeover offer for Aurora, moving the proposal directly to investors. Here’s what that could mean for product supply, delivery compliance, and DMV consumers.

As microdosing goes mainstream, here’s how to decide between a solo approach or working with a coach—plus DMV-specific considerations and compliance tips.

Ohio hemp businesses say adult-use enforcement creates a two-tier system favoring licensed marijuana dispensaries. Regulators counter that the 2023 voter-approved statute regulates marijuana—not hemp.

Georgia regulators reportedly believe federal rescheduling opens the door to mailing medical cannabis. Here’s what that signals for delivery laws, compliance, and the DMV.

New Jersey regulators are appealing a court loss to Curaleaf in a labor dispute. Here’s why delivery operators and consumers should watch the labor–licensing link.

A rare insurance-coverage clash in cannabis could ripple through delivery operators’ risk plans. Here’s what DMV consumers and couriers should watch now.

Retailers moved $284.9M in cannabis across adult-use and medical in H1 2026 as Texas-border traffic buoyed New Mexico’s market. Here’s what it signals and why DMV readers should care.

A second multistate operator has filed a federal challenge to New Jersey’s labor‑friendly cannabis licensing rule. Here’s how labor provisions intersect with delivery laws, compliance, and what DMV residents should watch.

MJBizDaily reports a $4.5M buy of PharmaCann’s New York medical cannabis permit by Grown Rogue, aiming at a shortage of indoor flower canopy. Here’s why it matters for cultivation, delivery compliance, and DMV consumers.

DEA released the marijuana rescheduling hearing transcript as ALJ Derek Julius weighs a Schedule III recommendation. Here’s what it could mean for DMV delivery compliance.

Texas spared hemp beverages in a recent crackdown, and Viola is prepping for a possible 3–5 mg federal cap. Here’s how the uncertainty could reshape delivery menus and compliance in the DMV.

State regulators say DEA guidance is essential to align medical cannabis rules with the new Schedule III status—especially for delivery, labeling, and patient access across the DMV.

Marijuana Venture’s 40 Under 40 nod for Rocco Del Priore spotlights a tech arms race. Here’s how bigger dev teams can shape cannabis delivery compliance in the DMV.

A one‑month reprieve pushes a federal hemp ban to December, sharpening tensions between hemp and cannabis advocates—and raising delivery compliance questions across the DMV.